<SEC-DOCUMENT>0001493152-24-023766.txt : 20240613
<SEC-HEADER>0001493152-24-023766.hdr.sgml : 20240613
<ACCEPTANCE-DATETIME>20240613195946
ACCESSION NUMBER:		0001493152-24-023766
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240611
FILED AS OF DATE:		20240613
DATE AS OF CHANGE:		20240613

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Brams Matthew
		CENTRAL INDEX KEY:			0001884361
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40874
		FILM NUMBER:		241042716

	MAIL ADDRESS:	
		STREET 1:		C/O CINGULATE INC.
		STREET 2:		1901 W. 47TH PLACE
		CITY:			KANSAS CITY
		STATE:			KS
		ZIP:			66205

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cingulate Inc.
		CENTRAL INDEX KEY:			0001862150
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				863825535
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1901 W. 47TH PLACE
		CITY:			KANSAS CITY
		STATE:			KS
		ZIP:			66205
		BUSINESS PHONE:		(913) 942-2300

	MAIL ADDRESS:	
		STREET 1:		1901 W. 47TH PLACE
		CITY:			KANSAS CITY
		STATE:			KS
		ZIP:			66205
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2024-06-11</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001862150</issuerCik>
        <issuerName>Cingulate Inc.</issuerName>
        <issuerTradingSymbol>CING</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001884361</rptOwnerCik>
            <rptOwnerName>Brams Matthew</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1901 W. 47TH PLACE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>KANSAS CITY</rptOwnerCity>
            <rptOwnerState>KS</rptOwnerState>
            <rptOwnerZipCode>66205</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>EVP and Chief Medical Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.18</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2024-06-11</value>
                <footnoteId id="F1"/>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>63324</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2034-03-04</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>63324</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>63324</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the &quot;Amendment&quot;). Cingulate's stockholders approved the Amendment on June 11, 2024.</footnote>
        <footnote id="F2">The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Shane J. Schaffer, Attorney-in-Fact</signatureName>
        <signatureDate>2024-06-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
